Countries Europe
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...
March 29, 2022 | News
Under the terms of the agreement, Xiel, a specialist distributor of Nuclear Medicine, Radiotherapy and Diagnostic Radiology technologies across the U.K. an...
March 29, 2022 | News
Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...
March 08, 2022 | News
CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...
March 08, 2022 | News
First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...
March 03, 2022 | News
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...
February 18, 2022 | News
Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in&n...
February 14, 2022 | News
Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...
February 11, 2022 | News
Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...
February 10, 2022 | News
"In our efforts to give patients access to new, innovative forms of therapy, it is our aim to fully benefit from the possibilities of digitization. Alex Th...
February 01, 2022 | News
This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...
January 19, 2022 | News
Quantitative results within 4 minutes of sampling facilitate rapid clinical decision-making at the point of care (POC) LumiraDx (Nasdaq: LMDX),...
January 12, 2022 | News
Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...
December 21, 2021 | News
· Artificial intelligence and wearable technology invented in UK is helping to diagnose and manage Pa...
December 14, 2021 | News
Most Read
Bio Jobs
News
Editor Picks